Allergy diagnostic performance of FastCheckPOC 20 Atopy

Area of Science:

• Allergy diagnostics
• Point-of-care testing
• Immunology

Background:

• Allergic diseases are increasing, posing a healthcare challenge.
• Accurate point-of-care tests are needed for primary care settings.
• This study evaluates a new test against a established method.

Purpose of the Study:

• To assess the diagnostic accuracy of the FastCheckPOC 20 Atopy (FCP20) test.
• To compare FCP20 performance against the Allergy Explorer 2 (ALEX2) multiplex assay.
• To determine the utility of FCP20 in primary healthcare for allergy screening.

Main Methods:

• A cross-sectional study involving 215 participants from South Tyrol, Italy.
• Serum samples analyzed using both FCP20 and ALEX2 assays.
• Sensitivity and specificity calculated using dichotomous data compared to ALEX2.

Main Results:

• Overall FCP20 sensitivity was 43.3% (95% CI: 40.3%-46.2%) and specificity was 92.1% (95% CI: 91.1%-93.0%).
• Inhalation allergens showed higher sensitivity than food allergens; grass pollen (gx17) had 79.8% sensitivity.
• Sensitivity exceeded 83% in patients with severe allergic symptoms, asthma, or eczema.

Conclusions:

• FCP20 exhibits high specificity, useful for excluding specific allergen sensitization.
• The low sensitivity of FCP20 restricts its use as a broad screening tool.
• Further evaluation needed for FCP20's role in specific clinical scenarios.